Can Mamdani Save Broadway?

The sudden closure of *Cats: The Jellicle Ball* highlights the precarious financial reality of modern Broadway, where high production costs and razor-thin margins often outweigh critical acclaim and strong attendance. Broadway suffers from "cost disease," where labor-intensive productions face rising expenses that ticket sales—even at high prices—struggle to cover. Unlike the West End, which benefits from robust government arts funding and lower labor costs, Broadway remains a high-risk environment where only massive hits or billionaire-backed productions consistently survive. While celebrity casting and dynamic pricing offer temporary relief, the industry’s long-term viability depends on finding sustainable models for unconventional, creative works. Theater critic at large Naveen Kumar notes that the tension between artistic innovation and the rigid economic structure of New York theater continues to threaten the survival of bold, culturally significant performances.